Neuroprotective effect of Panax notoginseng plysaccharides against focal cerebral ischemia reperfusion injury in rats

International Journal of Biological Macromolecules

Volumn 63, Issue , 2014, Pages 177-180

  Jia, Dong ^a   Deng, Yangbin ^b   Gao, Junxian ^c   Liu, Xiaoquan ^b   Chu, Jianping ^b   Shu, Ya ^d  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI AN CHILDREN S HOSPITAL   (China)

^c Ninth Hospital of xi'An   (China)

^d XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cerebral ischemia reperfusion; Cerebroprotective effect; Panax notoginseng; Polysaccharide

Indexed keywords

CASPASE 3; PANAX NOTOGINSENG POLYSACCHARIDE; POLYSACCHARIDE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INACTIVATION; FOCAL CEREBRAL ISCHEMIA REPERFUSION INJURY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR MECHANICS; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PANAX NOTOGINSENG; PLANT ROOT; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

MUS; PANAX NOTOGINSENG; RATTUS;

APOPTOSIS; CEREBRAL ISCHEMIA REPERFUSION; CEREBROPROTECTIVE EFFECT; PANAX NOTOGINSENG; POLYSACCHARIDE;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; HUMANS; MICE; NEUROPROTECTIVE AGENTS; PANAX NOTOGINSENG; POLYSACCHARIDES; RATS; REPERFUSION INJURY;

EID: 84888419401     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.10.034     Document Type: Article

References (24)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C. Circulation 2010, 121:e46-e215.
2. Ashafaq M., Khan M.M., Shadab Raza S., Ahmad A., Khuwaja G., Javed H., Khan A., Islam F., Siddiqui M.S., Safhi M.M., Islam F. Nutr. Res. 2012, 32:133-143.
3. Onténiente B., Couriaud C., Braudeau J., Benchoua A., Guégan C. Biochem. Pharmacol. 2003, 66:1643-1649.
4. Norris J.W., Hachinski V.C. Prevention of Stroke 1993, 1-15. Springer-Verlag, New York. J.W. Norris, V.C. Hachinski (Eds.).
5. Wang D., Yuan X., Liu T., Liu L., Hu Y., Wang Z., Zheng Q. Molecules 2012, 17:9803-9817.
6. Wu P.F., Zhang Z., Wang F., Chen J.G. Acta Pharmacol. Sin. 2010, 31:1523-1531.
7. Park S.J., Nam K.W., Lee H.J., Cho E.Y., Koo U., Mar W. Phytomedicine 2009, 16:1042-1051.
8. Gao H., Wang F.Z., Lien E.J., Trousdale M.D. Pharm. Res. 1996, 13:1196-1200.
9. Lam S.K., Ng T.B. Int. J. Biochem. Cell Biol. 2001, 33:287-292.
10. Bai Y., Zhang S.Y., Ren J., Yang Y.M., Liu M., Tang M.M.S., Kan M.Y. Chin. J. New Drugs Clin. Rem. 2001, 20:257-259.
11. Han J.A., Kuang Y.Q., Zhou H.T., Sun Z.H., Li K.H., Wei-yi H.U. Chin. J. Traumatol. 1999, 15:278-280.
12. Yang T.R., Kasai R., Zhou J., Tanaka O. Phytochemistry 1983, 22:1473-1478.
13. Ng T.B. J. Pharm. Pharmacol. 2006, 58:1007-1019.
14. Guo D.J., Yang W.T., Tian J., Deng Z.N., Liao W.J. Chin. J. Rehabili. 2003, 18:132-134.
15. Wang G.Y., Chen R., Chen B. J. Sichuan Tradit. Med. 2007, 25:14-16.
16. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Anal. Chem. 1956, 28:350-356.
17. Bradford M.M. Anal. Biochem. 1976, 72:248-254.
18. Filisetti-Cozzi T.M.C.C., Carpita N.C. Anal. Biochem. 1991, 197:157-162.
19. Aspey B.S., Alp M.S., Patel Y., Harrison1 M.J.G. Metab. Brain Dis. 1997, 12:237-249.
20. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Stroke 1989, 20:84-91.
21. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Stroke 1986, 17:1304-1308.
22. Block F., Kunkel M., Schwarz M. Neurosci. Lett. 1993, 149:126-128.
23. Miao S.S., Mao X.H., Pei R., Miao S.P., Xiang C., Lv Y.J., Yang X.G., Sun J., Jia S.S., Liu Y.P. Int. J. Biol. Macromol. 2013, 61:97-101.
24. Nagata S. Cell 1997, 88:355-365.